Birla Institute of Technology & Science School of Pharmacy Admission 2024-25, Placements, Results, News & Articles Details

Birla Institute of Technology & Science
Pilani, Rajasthan, India
Vidya Vihar Pilani, 333031 Rajasthan, India
333031
+91 1596 245073
info@bits-pilani.ac.in
https://www.bits-pilani.ac.in
About Us

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to "train young men and women able and eager to create and put into action such ideas, methods, techniques and information". The Institute is a dream come true of its founder late Mr G.D.Birla - an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi). What started in early 1900s as a small school, blossomed into a set of colleges for higher education, ranging from the Humanities to Engineering until 1964 when all these colleges amalgamated to culminate into a unique Indian University of International standing. This university was christened as the Birla Institute of Technology and Science, Pilani, known to many as BITS, Pilani.

Title in Pharmacy Birla Institute of Technology & Science

# Title Researcher Guide(s)
1 Investigation of Flow of Polarizable Particles Between Microelectrodes of Different Shapes Subjected to Nonuniform Electric Fields Prasad D. Nagendra Dr. Souri Banerjee
2 Magnetization Reversal Study in CoFe Magnetic Nanostructures Seshagiri Rao N.V.S.S. Dr. V.Satyanarayana Murthy
3 Strateic Plan for Effective Health Services Priyadarshi Shailendra Dr. Roy C R
4 Pharmacokinetics and Biodistribution Studies of Selected Racemic Drugs Dubey Sunil Kumar Dr. Saha Ranendra N.
5 Studies on Preparation Characterization and Pharmacokinetics of Etoposide Loaded Nanoparticles MOVVA SNEHALATHA Dr. Ranendra N. Saha
6 Characterization and Analysis of Plastid DNA of the Apicomplexan Parasite Plasmodium vivax from India VISHAL SAXENA Dr. Ashis K. Das
7 Studies on some Novel Approaches for Enhancement of Solubility and Bioavailability of Rifapentine a newer anti tubercular Drug Kole Prashant Laxman Dr. Ranendra N. Saha
8 Synthesis and Structure Activity Relationship of New Aryl and Heteroaryl Semicarbazones as Anticonvulsants Shalini Dr. P. Yogeeswari
9 Design Synthesis and Pharmacological Evaluation of Novel Phosphodiesterase FourInhibitors for their Anti Depressant and Anxiolytic Potential Muthu Venkatesh Sudali Dr. Mahesh R
10 Synthesis and Pharmacological Evaluation of Novel Heterocyclic Compounds as Potential Agents for the Treatment of Schizophrenia K.V.G. Chandra Sekhar Dr. V. S. RAO
11 Evaluation of topical formulations of selective cyclooxygenase 2 cox 2 inhibitiors for analgesic and antiinflammatory efficacy as well as plasma concentration profile Shirumalla Raj Kumar Dr. Abhijit Ray
12 Studies on the Drug Resistance Genes in Plasmodium falciparum and Plasmodium vivax from India SHILPI GARG Dr. Ashis K. Das
13 Synthesis and Pharmacological Studies of Substituted Quinazolin 4 ones for their Chemotherapeutic Activity Raghavendra NM Dr. P. P. THAMPI
14 Design Synthesis and Evaluation of Novel N linked Quinolone and Naphthyridone Analogs as Potential Antitubercular Agents SHAHUL HAMEED P Dr. D. SRIRAM
15 Synthesis and Biological Evaluation of Bacterial DNA Gyrase Inhibitors MANOJ C Dr. D. SRIRAM
16 Dual Inhibitors of ROCK I and NOX to Attenuate Neuroinflammation in Neurological Disorders High Throughput Virtual and Biological screening RESHMA CHOWDARY ALOKAM Dr. P. YOGEESWARI
17 Development of Human Silent Information Regulator 1 Modulators for Treatment of Cancer and Metabolic Disorders M. MALLIKA Dr. D. Sriram
18 quotDevelopment of Novel Isatin and#946; thiosemicarbazones for the Treatment of HIV TB Co infectionquot DEBJANI BANERJEE Dr. D. SRIRAM
19 Design Development and Pharmacokinetic Studies of Nanoparticulate Drug Delivery Systems of Imatinib Mesylate BENDE GIRISH SHAMRAO Dr. Ranendra N. Saha
20 quotInvestigation on Structure Activity Relationship of the Quinolone Derivatives against Mycobacterium tuberculosisquot P. SENTHIL KUMAR Dr. D. SRIRAM

13558

Universities

257881

Title

300

Department

252

Country